These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12566077)

  • 1. Apoptosis induction by the dual-action DNA- and protein-reactive antitumor drug irofulven is largely Bcl-2-independent.
    Herzig MC; Trevino AV; Liang H; Salinas R; Waters SJ; MacDonald JR; Woynarowska BA; Woynarowski JM
    Biochem Pharmacol; 2003 Feb; 65(4):503-13. PubMed ID: 12566077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells.
    Liang H; Salinas RA; Leal BZ; Kosakowska-Cholody T; Michejda CJ; Waters SJ; Herman TS; Woynarowski JM; Woynarowska BA
    Mol Cancer Ther; 2004 Nov; 3(11):1385-96. PubMed ID: 15542777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle effects and induction of premitotic apoptosis by irofulven in synchronized cancer cells.
    Woynarowski JM; Woynarowska BA; Trevino AV; Salinas R; Herman TS; Waters SJ; Macdonald JR
    Cancer Biol Ther; 2004 Nov; 3(11):1137-42; discussion 1143-4. PubMed ID: 15467441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irofulven induces apoptosis in breast cancer cells regardless of caspase-3 status.
    Herzig MC; Liang H; Johnson AE; Woynarowska B; Woynarowski JM
    Breast Cancer Res Treat; 2002 Jan; 71(2):133-43. PubMed ID: 11883439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irofulven (6-hydroxymethylacylfulvene, MGI 114) induces caspase 8 and 9-mediated apoptosis in human pancreatic adenocarcinoma cells.
    Wang W; Waters SJ; MacDonald JR; Von Hoff DD; Strodel WE; Miller AR
    Anticancer Res; 2001; 21(3B):1789-94. PubMed ID: 11497260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
    Dirsch VM; Stuppner H; Vollmar AM
    Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114).
    Woynarowski JM; Napier C; Koester SK; Chen SF; Troyer D; Chapman W; MacDonald JR
    Biochem Pharmacol; 1997 Dec; 54(11):1181-93. PubMed ID: 9416969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Bcl-2 in human epithelial tumor (HeLa) cells enhances clonogenic survival following exposure to 5-fluoro-2'-deoxyuridine or staurosporine, but not following exposure to etoposide or doxorubicin.
    Elliott MJ; Stribinskiene L; Lock RB
    Cancer Chemother Pharmacol; 1998; 41(6):457-63. PubMed ID: 9554589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.
    Wiltshire T; Senft J; Wang Y; Konat GW; Wenger SL; Reed E; Wang W
    Mol Pharmacol; 2007 Apr; 71(4):1051-60. PubMed ID: 17229870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new synthetic zerumbone pendant derivative (ZPD) on apoptosis induction and anti-migratory effects in human cervical cancer cells.
    Saranya J; Dhanya BP; Greeshma G; Radhakrishnan KV; Priya S
    Chem Biol Interact; 2017 Dec; 278():32-39. PubMed ID: 28987329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of Sox-4 in the cytochrome c-dependent AIF-independent apoptotic pathway in HeLa cells induced by Delta12-prostaglandin J2.
    Kim BE; Lee JH; Kim HS; Kwon OJ; Jeong SW; Kim IK
    Exp Mol Med; 2004 Oct; 36(5):444-53. PubMed ID: 15557816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
    Schmitt E; Steyaert A; Cimoli G; Bertrand R
    Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irofulven (6-hydroxymethylacylfulvene, MGI 114)-induced apoptosis in human pancreatic cancer cells is mediated by ERK and JNK kinases.
    Wang W; Waters SJ; MacDonald JR; Roth C; Shentu S; Freeman J; Von Hoff DD; Miller AR
    Anticancer Res; 2002; 22(2A):559-64. PubMed ID: 12014623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTX-8, a cytotoxic L-amino acid oxidase isolated from Agkistrodon acutus snake venom, induces apoptosis in Hela cervical cancer cells.
    Zhang L; Wei LJ
    Life Sci; 2007 Mar; 80(13):1189-97. PubMed ID: 17275856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
    Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
    Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generation.
    Hoffmann R; von Schwarzenberg K; López-Antón N; Rudy A; Wanner G; Dirsch VM; Vollmar AM
    Biochem Pharmacol; 2011 Sep; 82(5):453-63. PubMed ID: 21669190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line.
    Kamarajan P; Sun NK; Sun CL; Chao CC
    FEBS Lett; 2001 Sep; 505(2):206-12. PubMed ID: 11566177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pomolic acid may overcome multidrug resistance mediated by overexpression of anti-apoptotic Bcl-2 proteins.
    Fernandes J; Weinlich R; Castilho RO; Amarante-Mendes GP; Gattass CR
    Cancer Lett; 2007 Jan; 245(1-2):315-20. PubMed ID: 16517065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irofulven: resurgence for alkylating therapy in cancer?
    Dent P; Grant S
    Cancer Biol Ther; 2004 Nov; 3(11):1143-4. PubMed ID: 15640616
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
    Walczak H; Bouchon A; Stahl H; Krammer PH
    Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.